| ²é¿´: 455 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö £¬µã»÷ÕâÀï½øÐв鿴 | ||
xiandongzengľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖúWOSÈë²ØºÅ
|
|
| ÇóÖúWOSÈë²ØºÅ,DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis, Oncotarget, 2017,8(64): 107612¨C107620. |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ÖØÇì´óѧ085700×ÊÔ´Óë»·¾³×Ü·Ö308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
306Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧѧ˶080502 337Çóµ÷¼Á-Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
313Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Äϲý´óѧ²ÄÁÏר˶311·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
316Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
346Çóµ÷¼Á[0856]
ÒѾÓÐ7È˻ظ´
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658104
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.1Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xiandongzeng: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, 3Ks 2018-09-18 09:12:29
Ðľ²_ÒÀÈ»: LS-EPI+1, ¸ÐлӦÖú 2018-09-19 08:37:31
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xiandongzeng: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, 3Ks 2018-09-18 09:12:29
Ðľ²_ÒÀÈ»: LS-EPI+1, ¸ÐлӦÖú 2018-09-19 08:37:31
|
DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis ×÷Õß:Li, JX (Li, Junxin)[ 1,2 ] ; Xie, N (Xie, Ni)[ 3 ] ; Yuan, JH (Yuan, Jianhui)[ 4 ] ; Liu, LY (Liu, Lvyan)[ 1 ] ; Zhou, QM (Zhou, Qiming)[ 5 ] ; Ren, XH (Ren, Xiaohu)[ 4 ] ; Chen, Q (Chen, Qian)[ 1,2 ] ; Zhang, GZ (Zhang, Guizhong)[ 1 ] ; Ruan, QG (Ruan, Qingguo)[ 1 ] ; Chen, YHH (Chen, Youhai H.)[ 6 ] ...¸ü¶àÄÚÈÝ ONCOTARGET ¾í: 8 ÆÚ: 64 Ò³: 107612-107620 DOI: 10.18632/oncotarget.22544 ³ö°æÄê EC 8 2017ÎÄÏ×ÀàÐÍ:Article ²é¿´ÆÚ¿¯Ó°ÏìÁ¦ ÕªÒª Decoy receptor 3 (DcR3) is abnormally up-regulated in many cancer cells. It may help cancer cells to escape from immune surveillance and establish metastatic lesions. However, whether DcR3 can be used as a biomarker for the diagnosis of cancer metastasis is unclear. In this study, sera from healthy controls and patients with different cancers were collected, and tested for their DcR3 levels by ELISA. Significantly elevated DcR3 levels were observed in the sera of patients with gastric cancer (2.04 +/- 1.01, P = 0.0061), lymphoma (1.62 +/- 0.75, P = 0.041), and breast cancer (1.53 +/- 0.51, P = 0.023). DcR3 was found to be a suitable biomarker for identifying gastric cancer patients. Importantly, DcR3 was positively associated with platelet distribution width (PDW) (P = 2.45 x 10(-6), R = 0.63) in metastatic cancers but negatively associated with hemoglobin (HGB) (P = 0.002, R = -0.59) and hematocrit (HCT) (P = 0.001, R = -0.62) in non-metastatic cancers. Combined with PDW, HGB and HCT, serum DcR3 could be used to predict the occurrence of cancer metastasis. These findings indicate that DcR3 could be used as a biomarker for the diagnosis of gastric cancer, and for cancer metastasis in combination with hematological traits. ¹Ø¼ü´Ê ×÷Õ߹ؼü´Ê cR3; PDW; HGB; HCT; metastasisKeyWords Plus ECOY RECEPTOR-3; E-CADHERIN; GASTRIC-CANCER; CELL-ADHESION; COLON-CANCER; EXPRESSION; PROGRESSION; CARCINOMA; APOPTOSIS; CATENIN×÷ÕßÐÅÏ¢ ͨѶ×÷ÕßµØÖ·: Wan, XC (ͨѶ×÷Õß) ÏÔʾ¸ü¶à Univ City Shenzhen, Shenzhen Lab Fully Human Antibody Engn, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol,Chinese Acad Sci, Shenzhen 518055, Peoples R China. µØÖ·: ÏÔʾ¸ü¶à [ 1 ] Univ City Shenzhen, Shenzhen Lab Fully Human Antibody Engn, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol,Chinese Acad Sci, Shenzhen 518055, Peoples R China ÏÔʾ¸ü¶à [ 2 ] Univ Chinese Acad Sci, Beijing 100049, Peoples R China ÏÔʾ¸ü¶à [ 3 ] Shenzhen Second Peoples Hosp, Inst Translat Med, Shenzhen 518035, Peoples R China [ 4 ] Shenzhen Ctr Dis Control & Prevent, Inst Toxicol, Shenzhen 518055, Peoples R China [ 5 ] Nanshan Hosp Shenzhen, Dept Oncol, Shenzhen 518055, Peoples R China ÏÔʾ¸ü¶à [ 6 ] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA µç×ÓÓʼþµØÖ·:xc.wan@siat.ac.cn »ù½ð×ÊÖúÖÂл »ù½ð×ÊÖú»ú¹¹ ÊÚȨºÅ Shenzhen Peacock Team Project 1110140040347265 Fourth Batch of Talents Project in Guangdong Province 2014-1 Nature Science Foundation of China 81373112 Shenzhen Special Funds of Industry in the Future 2015-971 Shenzhen Municipal Development and Reform Commission (NDRC) Engineering Laboratory Project 2014-1782 Project of Guangdong Natural Science Foundation 2016A030310033 Project of Shenzhen Basic Research Plan JCYJ20150402102135491 JCYJ201603 28161613864 Shenzhen Technology Innovation Progect JSGG20160229202150023 JSGG20140701164558078 JCYJ20150330102720122 Project of Shenzhen International Cooperation Foundation GJHZ201603 01163138685 GJHZ20130412153906740 Natural Science Foundation of Guangdong 2016A030313029 Natural Science Foundation of China 81501356 Project of Guangdong Scientific Plan Foundation 2013A022100037 2013B021800097 2014A020212038 ²é¿´»ù½ð×ÊÖúÐÅÏ¢ ³ö°æÉÌ IMPACT JOURNALS LLC, 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA Àà±ð / ·ÖÀà Ñо¿·½Ïò:Oncology; Cell Biology Web of Science Àà±ð:Oncology; Cell Biology ÎÄÏ×ÐÅÏ¢ ÓïÑÔ:English Èë²ØºÅ: WOS:000419564600024 PubMed ID: 29296192 ISSN: 1949-2553 ÆäËûÐÅÏ¢ IDS ºÅ: FS1UR Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 41 Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 0 |
2Â¥2018-09-18 08:48:11













»Ø¸´´ËÂ¥
EC 8 2017